APA ציטוט

Xin, P., Li, C., Zheng, Y., Peng, Q., Xiao, H., Huang, Y., & Zhu, X. (2017). Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines. Drug Des Devel Ther.

Citação norma Chicago

Xin, Pengliang, Chuntuan Li, Yan Zheng, Qunyi Peng, Huifang Xiao, Yuanling Huang, and Xiongpeng Zhu. "Efficacy of the Dual PI3K and MTOR Inhibitor NVP-BEZ235 in Combination With Imatinib Mesylate against Chronic Myelogenous Leukemia Cell Lines." Drug Des Devel Ther 2017.

ציטוט MLA

Xin, Pengliang, et al. "Efficacy of the Dual PI3K and MTOR Inhibitor NVP-BEZ235 in Combination With Imatinib Mesylate against Chronic Myelogenous Leukemia Cell Lines." Drug Des Devel Ther 2017.